Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis

Microbes and Infection

Volumn 9, Issue 4, 2007, Pages 483-489

  Peres, Camila M ^a   de Paula, Lúcia ^a   Medeiros, Alexandra I ^a   Sorgi, Carlos A ^a   Soares, Edson G ^a   Carlos, Daniela ^a   Peters Golden, Marc ^b   Silva, Célio L ^a   Faccioli, Lúcia H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Medical School   (United States)

Author keywords

5 LO metabolites; Cytokines; Immunomodulation; Lung inflammation; M. tuberculosis

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; GAMMA INTERFERON; INTERLEUKIN 12; LEUKOTRIENE; LEUKOTRIENE B4; LIPOXIN A; LIPOXYGENASE INHIBITOR; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DISEASE MODEL; ENZYME ACTIVITY; ENZYME INHIBITION; HOST RESISTANCE; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; TUBERCULOSIS;

ANIMALS; CYTOKINES; FEMALE; INDOLES; LEUKOCYTES; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; LIPOXINS; LIPOXYGENASE INHIBITORS; LUNG; MALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; TH1 CELLS; TUBERCULOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 33947308772     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.01.006     Document Type: Article

References (30)

1. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russel D.G., and Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178 (1993) 2243-2247
2. Cooper A.M., Magram J., Ferrante J., and Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186 (1997) 39-45
3. Lowrie D.B., and Silva C.L. Enhancement of immunocompetence in tuberculosis by DNA vaccination. Vaccine 18 (2000) 1712-1716
4. Ford-Hutchinson A.W., Bray M.A., Doig M.V., Shipley M.E., and Smith M.J. Leukotriene a potent chemokinetic aggregating substance released from polymorphonuclear leukocytes. Nature 286 (1980) 264-265
5. Marcinkiewicz J., Grabowska A., Bryniarski K., and Chain B.M. Enhancement of CD4+ T-cell-dependent interleukin-2 production in vitro by murine alveolar macrophages: the role of leukotriene B4. Immunology 91 (1997) 369-374
6. Smith M.J.H., Ford-Hutchinson A.W., and Bray M.A. Leukotriene a potential mediator of inflammation. J. Pharm. Pharmacol. 32 (1980) 517-518
7. Bailie M.B., Standiford T.J., Laichalk L.L., Coffey M.J., Strieter R., and Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumoniae in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157 (1996) 5221-5224
8. Medeiros A.I., Sá-Nunes A., Soares E.G., Peres C.M., Silva C.L., and Faccioli L.H. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect. Immun. 72 (2004) 1637-1644
9. Peters-Golden M., Canetti C., Mancuso P., and Coffey M.J. Leukotrienes: underappreciated mediators of innate immune response. J. Immunol. 173 (2005) 589-594
10. Hopkins H., Stull T., Von Essen S.G., Robbins R.A., and Rennard S.I. Neutrophil chemotactic factors in bacterial pneumonia. Chest 95 (1989) 1021-1027
11. Medeiros A.I., Silva C.L., Malheiro A., Maffei C.M., and Faccioli L.H. Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the β-glucan present in their cell wall. Br. J. Pharmacol. 128 (1999) 1529-1537
12. Coffey M.J., Phare S.M., and Peters-Golden M. Role of leukotrienes in killing of Mycobacterium bovis by neutrophils. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 185-190
13. Aliberti J., Serhan C., and Sher A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196 (2002) 1253-1262
14. Bonato V.L., Gonçalves E.D., Soares E.G., Santos Jr. R.R., Sartori A., Coelho-Castelo A.A., and Silva C.L. Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+cells, interferon-gamma recovery and reduction of lung injury. Immunology 113 (2004) 130-138
15. Faccioli L.H., Souza G.E., Cunha F.Q., Poole S., and Ferreira S.H. Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions 30 (1990) 344-349
16. Stuehr D.J., and Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169 (1989) 1543-1555
17. Lima V.M., Bonato V.L., Dos Santos S.A., Dos Santos R.R., Goncalves E.D., Faccioli L.H., Brandao I.T., Rodrigues-Junior J.M., and Silva C.L. Role of trehalose dimycolate in recruitment of cells and modulation of production of production of cytokines and NO in tuberculosis. Infect. Immun. 69 (2001) 5305-5312
18. Bafica A., Scanga C.A., Serhan C., Machado F., White S., Sher A., and Aliberti J. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 115 (2005) 1601-1606
19. Mancuso P., Standiford T.J., Marshall T., and Peters-Golden M. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect. Immun. 66 (1998) 5140-5146
20. Mancuso P., Nana-Sinkam P., and Peters-Golden M. Leukotriene B4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infect. Immun. 69 (2001) 2011-2016
21. Larfars G., Lantoine F., Devynck M.A., Palmblad J., and Gyllenhammar H. Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes. Blood 93 (1999) 1399-1405
22. Gagnon L., Filion L.G., Dubois C., and Rola-Pleszczinski M. Leukotrienes and macrophage activation: augmented cytotoxic activity and enhanced interleukin 1, tumor necrosis factor and hydrogen peroxide production. Agents Actions 26 (1989) 141-147
23. Cooper A.M., Roberts A.D., Rhoades E., Callahan J.E., Getzy D.M., and Orme I.M. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84 (1995) 423-432
24. Tager A.M., Bromley S.K., Medoff B.D., Islam S.A., Bercury S.D., Friedrich E.B., Carafone A.D., Gerszten R.E., and Luster A.D. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4 (2003) 982-990
25. Hebert M.J., Takano T., Holthofer H., and Brady H.R. Sequential morphologic events during apoptosis of human neutrophils: modulation by lipoxygenase-derived eicosanoids. J. Immunol. 157 (1996) 3105-3115
26. Huang L., Zhao A., Wong F., Ayala J.M., Struthers M., Ujjainwalla F., Wright S.D., Springer M.S., Evans J., and Cui J. Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1783-1788
27. Ladel C.H., Blum C., Reifenberg A., Kopf M., and Kaufmann S.H.E. Lethal tuberculosis in inteleukin-6-deficient mice. Infect. Immun. 65 (1997) 4843-4849
28. Law K., Weiden M., Harkin T., Tchou-Wong K., Chi C., and Rom W.N. Increased release of interleukin-1 beta, interkeukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavage from sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153 (1996) 799-804
29. Coffey M., Phare S.M., Cinti S., Peters-Golden M., and Kazanjian P.H. Granulocyte-macrophage colony-stimulating factor upregulates reduced 5-lipoxygenase metabolism in peripheral blood monocytes and neutrophils in AIDS. Blood 94 (1999) 3897-3905
30. Skerret S., Henderson W., and Martin T. Alveolar macrophage function in rats with severe protein calorie malnutrition: arachidonic acid metabolism, cytokine release, and antimicrobial activity. J. Immunol. 144 (1990) 1052-1061